Recent studies have highlighted FOXK2’s role in metabolic disorders, particularly in promoting glycolysis and contributing to pulmonary fibrosis through the circHIPK3/miR-30a-3p/FOXK2 pathway (39). This evidence concerns the gene FOXK2 and Other metabolic disease.